{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T07:54:24Z","timestamp":1774511664795,"version":"3.50.1"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2014,10,29]],"date-time":"2014-10-29T00:00:00Z","timestamp":1414540800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0111477","type":"journal-article","created":{"date-parts":[[2014,10,29]],"date-time":"2014-10-29T18:40:35Z","timestamp":1414608035000},"page":"e111477","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["Bone Health History in Breast Cancer Patients on Aromatase Inhibitors"],"prefix":"10.1371","volume":"9","author":[{"given":"Marilyn L.","family":"Kwan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan C.","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecile A.","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janise M.","family":"Roh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malini","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa E.","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Chen","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara","family":"Sucheston-Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawn L.","family":"Hershman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles P.","family":"Quesenberry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine B.","family":"Ambrosone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence H.","family":"Kushi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,10,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1200\/JCO.20.3.751","article-title":"Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study","volume":"20","author":"J Geisler","year":"2002","journal-title":"J Clin Oncol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.1200\/JCO.2006.07.5382","article-title":"Aromatase inhibitors and bone health in women with breast cancer","volume":"24","author":"AJ Chien","year":"2006","journal-title":"J Clin Oncol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ncponc1015","article-title":"Switching to anastrozole after tamoxifen improves survival in postmenopausal women with breast cancer","volume":"5","author":"F Boccardo","year":"2008","journal-title":"Nat Clin Pract Oncol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1200\/JCO.2009.23.1274","article-title":"Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen","volume":"28","author":"M Dowsett","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1200\/JCO.2009.26.3756","article-title":"American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer","volume":"28","author":"HJ Burstein","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.critrevonc.2008.07.013","article-title":"Aromatase inhibitor-associated bone loss in breast cancer patients is distinct from postmenopausal osteoporosis","volume":"69","author":"P Hadji","year":"2009","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1200\/JCO.2003.08.017","article-title":"American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer","volume":"21","author":"BE Hillner","year":"2003","journal-title":"J Clin Oncol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s00198-007-0439-4","article-title":"Management of cancer treatment-induced bone loss in early breast and prostate cancer \u2013 a consensus paper of the Belgian Bone Club","volume":"18","author":"JJ Body","year":"2007","journal-title":"Osteoporos Int"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ctrv.2008.03.007","article-title":"Guidance for the management of breast cancer treatment-induced bone loss: a consensus position statement from a UK Expert Group","volume":"34","author":"DM Reid","year":"2008","journal-title":"Cancer Treat Rev"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Gralow JR, Biermann JS, Farooki A, Fornier MN, Gagel RF, <etal>et al<\/etal>.. (2013) NCCN Task Force Report: Bone Health In Cancer Care. J Natl Compr Canc Netw 11 Suppl 3: S1\u201350; quiz S51.","DOI":"10.6004\/jnccn.2013.0215"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00198-006-0306-8","article-title":"Enhanced prediction of fracture risk combining vertebral fracture status and BMD","volume":"18","author":"ES Siris","year":"2007","journal-title":"Osteoporos Int"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1210\/jc.2006-1476","article-title":"Risk factors for fracture in nonosteoporotic men and women","volume":"92","author":"ND Nguyen","year":"2007","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJM199503233321202","article-title":"Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group","volume":"332","author":"SR Cummings","year":"1995","journal-title":"The New England journal of medicine"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1001\/jama.298.20.2389","article-title":"Factors associated with 5-year risk of hip fracture in postmenopausal women","volume":"298","author":"J Robbins","year":"2007","journal-title":"Jama"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/annonc\/mdr356","article-title":"High prevalence of vertebral fractures in women with breast cancer starting aromatase inhibitor therapy","volume":"23","author":"B Bouvard","year":"2012","journal-title":"Annals of oncology: official journal of the European Society for Medical Oncology\/ESMO"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.breast.2011.09.001","article-title":"Bone health in a prospective cohort of postmenopausal women receiving aromatase inhibitors for early breast cancer","volume":"21","author":"S Servitja","year":"2012","journal-title":"Breast"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s10552-008-9170-5","article-title":"The Pathways Study: a prospective study of breast cancer survivorship within Kaiser Permanente Northern California","volume":"19","author":"ML Kwan","year":"2008","journal-title":"Cancer Causes Control"},{"key":"ref18","unstructured":"Oehrli MD, Quesenberry CP (2013) 2013 Annual Report on Trends, Incidence, and Outcomes. Kaiser Permanente, Northern California Cancer Registry."},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1097\/00005768-200111000-00024","article-title":"Validation of the Arizona Activity Frequency Questionnaire using doubly labeled water","volume":"33","author":"LK Staten","year":"2001","journal-title":"Med Sci Sports Exerc"},{"key":"ref20","unstructured":"Selby JV, Smith DH, Johnson ES, Raebel MA, Friedman GD, <etal>et al<\/etal>.. (2005) Kaiser Permanente Medical Care Program. In: BL S, editor. Pharmacoepidemiology. West Sussex: John Wiley &amp; Sons, Ltd. 241\u2013259."},{"key":"ref21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jbo.2014.03.002","article-title":"Femur fracture classification in women with a history of breast cancer","volume":"3","author":"S Chau","year":"2014","journal-title":"Journal of Bone Oncology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1001\/jama.286.22.2815","article-title":"Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment","volume":"286","author":"ES Siris","year":"2001","journal-title":"JAMA: the journal of the American Medical Association"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s00198-004-1680-8","article-title":"Osteoporosis is markedly underdiagnosed: a nationwide study from Denmark","volume":"16","author":"P Vestergaard","year":"2005","journal-title":"Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/jbmr.378","article-title":"Better skeletal microstructure confers greater mechanical advantages in Chinese-American women versus white women","volume":"26","author":"XS Liu","year":"2011","journal-title":"Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/jbmr.352","article-title":"Differences in bone microarchitecture between postmenopausal Chinese-American and white women","volume":"26","author":"MD Walker","year":"2011","journal-title":"Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1007\/s00198-011-1855-z","article-title":"Volumetric bone mineral density at the spine and hip in Chinese American and White women","volume":"23","author":"MD Walker","year":"2012","journal-title":"Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJMoa055218","article-title":"Calcium plus vitamin D supplementation and the risk of fractures","volume":"354","author":"RD Jackson","year":"2006","journal-title":"N Engl J Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1210\/jc.2006-2437","article-title":"Breast cancer and the risk of osteoporotic fracture: A paradox","volume":"92","author":"R Eastell","year":"2007","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"ref29","unstructured":"National Osteoporosis Foundation (2002) America\u2019s Bone Health: The State of Osteoporosis and Low Bone Mass in Our Nation. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/noforg\/files\/nof\/public\/content\/file\/63\/upload\/49pdf\" xlink:type=\"simple\">http:\/\/noforg\/files\/nof\/public\/content\/file\/63\/upload\/49pdf<\/ext-link>. Accessed 2014 Jun 13."},{"key":"ref30","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1089\/jwh.2012.3687","article-title":"Bone mineral density screening among women with a history of breast cancer treated with aromatase inhibitors","volume":"22","author":"L Spangler","year":"2013","journal-title":"Journal of women's health"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1200\/JCO.2012.42.2097","article-title":"Bone health in adult cancer survivorship","volume":"30","author":"MB Lustberg","year":"2012","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0111477","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T02:56:36Z","timestamp":1588992996000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0111477"}},"subtitle":[],"editor":[{"given":"Debashis","family":"Ghosh","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,10,29]]},"references-count":31,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2014,10,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0111477","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,29]]}}}